Arthur Ide, MD
Dermatology · Edina, MNNPI 1538128814
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.3% of the total across 63 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 17.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2024 at $274 and has fallen 63.1% since, to $101 in 2025.
Across 63 payments — averaging $17.61 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$193
- Sanofi$115
- Sun Pharmaceutical Industries Inc.$103
- Lilly USA, LLC$98
- Johnson & Johnson$91
- Incyte Corporation$83
- plus $426 from 18 others
What the payments were for
- Food & beverage$1,08097%
- Education$303%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 10 | $193 |
| Sanofi | 6 | $115 |
| Sun Pharmaceutical Industries Inc. | 6 | $103 |
| Lilly USA, LLC | 5 | $98 |
| Johnson & Johnson | 5 | $91 |
| Incyte Corporation | 4 | $83 |
| Galderma Laboratories, L.p. | 4 | $67 |
| Amgen | 3 | $41 |
| Biofrontera Inc. | 3 | $40 |
| Verrica Pharmaceuticals Inc. | 2 | $31 |
| AbbVie | 2 | $25 |
| Boehringer Ingelheim | 1 | $24 |
| Bristol Myers Squibb | 1 | $22 |
| Kyowa Kirin, Inc. | 1 | $21 |
| VYNE Pharmaceuticals Inc. | 1 | $20 |
| Janssen Scientific Affairs, LLC | 1 | $18 |
| Dermavant Sciences, Inc. | 1 | $16 |
| E.r. Squibb & Sons, L.L.C. | 1 | $16 |
| LEO Pharma Inc. | 1 | $16 |
| Pierre Fabre Pharmaceuticals, Inc. | 1 | $14 |
| Biocon Biologics Inc | 1 | $14 |
| Arcutis Biotherapeutics, Inc. | 1 | $14 |
| UCB, Inc. | 1 | $14 |
| Pfizer | 1 | $13 |
How this compares
$1,110 in reported general payments places this provider in the 80th percentile of 273 dermatology providers in Minnesota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluocinonide | 107 | $4,042 |
| Fluorouracil | 43 | $4,005 |
| Doxycycline Monohydrate | 50 | $1,893 |
| Ketoconazole | 101 | $1,831 |
| Imiquimod | 64 | $1,718 |
| Doxycycline Hyclate | 25 | $1,430 |
| Triamcinolone Acetonide | 84 | $1,050 |
| Minocycline Hcl | 24 | $780 |
| Desoximetasone | 11 | $745 |
| Desonide | 20 | $473 |
| Hydroxychloroquine Sulfate | 16 | $326 |
| Hydrocortisone | 56 | $292 |
| Clobetasol Propionate | 11 | $220 |
| ValacyclovirValacyclovir Hcl | 20 | $207 |
| Mupirocin | 30 | $187 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Edina
- Mimi ChoEdina$2K
- Marie BridenEdina$2K
- Michelle BussmannEdina$1K
- Kristina ShafferEagan$538K
- Margareth Pierre-LouisMinneapolis$439K
- Maria HordinskyMinneapolis$85K
- Afsaneh AlaviRochester$71K
- Todd SeelhammerSaint Paul$63K
- Brittney SchultzMinneapolis$52K
- David PearsonMinneapolis$46K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.